Moffitt Centers of Excellence Expand
Webster’s dictionary defines the word “excellence” as “the quality of being excellent” and the word “excellent” as “superior, very good of its kind, eminently good.”
Moffitt’s three Centers of Excellence are continuing the Moffitt tradition of excellence in research and patient care by “raising the bar” for excellence to even higher levels. This ongoing pursuit of excellence is being accomplished on several fronts: obtaining large research grants, filing patents, engaging in bench-to-bedside research to test novel drugs and treatments, studying those discoveries in clinical trials, and making a global impact in the goal to prevent and cure cancer.
“Translational science is about taking fundamental discoveries from the laboratory bench to the bedside and the population by way of clinical trials to assess the safety and effectiveness of new preventive and therapeutic strategies – such as testing new drugs, repurposing or combining existing drugs, or developing vaccines to prevent or treat cancer,” says Thomas A. Sellers, Ph.D., M.P.H., executive vice president and center director of Moffitt Cancer Center.
Because it bridges scientific discoveries with clinical delivery, translational science ultimately benefits cancer patients and provides a basis for developing new technologies,” says James J. Mulé, Ph.D., associate center director, Translational Science. “Therefore, translational science is a critical component of Moffitt’s Centers of Excellence, currently focused on lung cancer, melanoma and infection research in cancer.”
Learn more about how the physicians and scientists working in Moffitt’s Centers of Excellence link discoveries, technology and clinical applications. Much of their research concentrates on providing evidence-based treatment decisions, also called “personalized medicine.”
Link to features on Moffitt's Centers of Excellence: